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Abstract 
The Podoplanin-CLEC-2 axis is critical in mice for prevention of haemorrhage in the cerebral 
vasculature during mid-gestation.  This raises the question as to how platelets are captured 
by podoplanin on neuroepithelial cells in a high shear environment. In this study, we 
demonstrate that mouse platelets form stable aggregates on mouse podoplanin at arterial 
shear through a CLEC-2 and Src kinase-dependent pathway. Adhesion and aggregation are 
also dependent on the platelet glycoprotein (GP) receptors, integrin αIIbβ3 and GPIb, and 
the feedback agonists ADP and thromboxane A2 (TxA2).  CLEC-2 does not bind to von 
Willebrand factor (VWF) suggesting that the interaction with podoplanin is sufficient to  
both tether and activate platelets.  Consistent with this, surface plasmon resonance 
measurements reveal that mouse CLEC-2 binds to mouse podoplanin with nanomolar 
affinity. The present findings demonstrate a novel pathway of haemostasis in which 
podoplanin supporting platelet capture and activation at arteriolar rates of shear. 
  
Page 2 of 25
URL: http://mc.manuscriptcentral.com/cpla E-mail: P.Harrison.1@bham.ac.uk
Platelets
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
3 
 
Introduction 
The C-type lectin-like receptor CLEC-2 is a type II transmembrane protein expressed on the 
surface of platelets, megakaryocytes and a subset of activated dendritic cells [1,2] The CLEC-
2 cytosolic tail contains a single YxxL sequence known as a hemITAM which is 
phosphorylated following ligand engagement through recruitment of Src family and Syk 
tyrosine kinases [3-5]. This initiates a Syk kinase-driven signalling pathway which leads to 
powerful activation of platelets through PLCγ2 [6,7,5,8].  
The interaction of platelet CLEC-2 with its endogenous ligand podoplanin plays a critical role 
in development of the cerebral vasculature and lymphatic system in mice [9-13]. Post-
development, CLEC-2 and podoplanin are required for prevention of haemorrhage in high 
endothelial vessels and at sites of inflammatory challenge [14,15]. However, CLEC-2 is not 
thought to have a significant role in haemostasis, as tail bleeding times are not altered in 
mice deficient in the C-type lectin-like receptor [16,12,17].  This is consistent with the 
absence of a recognized ligand for CLEC-2 in the vasculature. The presence of podoplanin on 
a wide variety of cell types including lymphatic endothelial cells, type 1 alveolar cells, kidney 
podocytes and the choroid plexus epithelium, as well as its up-regulation on macrophages 
and TH17 T-cells, suggests important roles for the podoplanin-CLEC-2 axis beyond the 
vasculature [18]. 
Mice deficient in CLEC-2 or podoplanin exhibit haemorrhaging in the brain during mid 
gestation [10]. Podoplanin is expressed at high level on the neuroepithelium in development 
but becomes restricted to the choroid plexus and brain lymphatic vessels during late 
gestation and in the adult brain.  Haemorrhaging in the cerebrovasculature is also present in 
mice deficient in Syk and the αIIb-subunit of integrin αIIbβ3 suggesting that it is mediated 
through the loss of CLEC-2 driven platelet aggregation [10].  
Intraventricular haemorrhaging (IVH) occurs in approximately 25% of human infants born 
with a birthweight of less than 1500 g [19] and is believed to be due to cardiovascular and 
respiratory instability. However, many of these infants also have severe thrombocytopenia, 
although there is no direct relationship between platelet count and IVH [20,21].  These 
results demonstrate the need to further understand the molecular basis of platelet 
activation in the cerebrovasculature during development. 
Shear rates of flow in the cerebral arterioles in neonatal and adult mouse brains are in the 
order 1000 s
-1
 and above [22,23]. We have shown that recombinant human podoplanin 
captures and activates human platelets at venous but not arterial rates of shear [24], 
consistent with the relatively low affinity of human podoplanin and human CLEC-2 of 24.5 
µM  [25]. In contrast, in the present study we show that mouse podoplanin is able to 
support adhesion and aggregation of mouse platelets at arteriolar rates of shear due to a 
three orders of magnitude greater affinity of mouse podoplanin for mouse CLEC-2. This 
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suggests a fundamental difference in the role of podoplanin and CLEC-2 in mouse relative to 
human. 
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Methods 
Materials 
The following were from the sources shown: glass capillaries tubes (Cambridge UK), 
dasatinib (Sigma, Poole, UK), cangrelor (Medicines company, Place, UK), indomethacin 
(Sigma, Poole,UK), p0p/B antibody (Emfret, Germany); eptifibatide (Queen Elizabeth 
Hospital Pharmacy, UK); Polyclonal rabbit anti-VWF (Dako); anti-mouse CLEC-2 antibody 
(clone 17D9; Bio-Rad), and anti-mouse PDPN (clone 8.1.1; eBioscience).  Other reagents 
were from previously described sources. 
Mouse strains  
Animal experimentation was performed with ethical approval from the UK Home Office, 
(PPL 70/8286). All experiments were performed on a C57Bl/6J background. Floxed CLEC-2 
mice (CLEC-2
fl/fl
) were crossed with PF4 Cre mice as previously described [9]. Controls were 
CLEC-2
fl/fl
 mice. 
Recombinant mouse podoplanin expression 
Fc mPodoplanin (mPdpn-Fc) was generated as previously described [26]. The vector pHLsec 
was used for expression of His-tagged mPdpn (mPdpn-His). For expression and purification 
of the His-tagged fusion protein, the expression vector was transfected into 293T cells using 
polyethylenimine transfection. The fusion protein was purified from cell culture 
supernatants by affinity chromatography using Ni-NTA beads (Qiagen), eluted with 60% 
imidazole solution, and dialyzed into phosphate-buffered saline (PBS). Purity was 
determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
western blotting using an anti-His tag antibody. 
Recombinant mouse CLEC-2 expression 
A fusion protein of amino acids 55-229 of the mCLEC-2 ECD fused to an N terminal 6xHIS tag 
was generated using the amplification primers 
GGAACCGGTCATCATCACCATCACCATCACCATACACAGCAAAAGTATCTA and 
CGTGGTACCTTAAAGCAGTTGGTCCACTCT.  The PCR product was cloned into the expression 
vector pHLsec and expressed in 293T cells using polyethylenimine transfection.  The fusion 
protein was purified from cell culture supernatants by affinity chromatography using a 1ml 
HisTrap HP (GE Healthcare) and eluted using imidazole solution and dialysed into PBS. 
Fusion protein purity was investigated by SDS-PAGE and western blotting with an anti-His 
antibody.  The mCLEC-2-rFc plasmid was a kind gift from Sophie Acton and Shannon Turley 
[27].  This was used to make a stable cell line which secreted the recombinant protein into 
the cell media.  mCLEC-2-rFc was purified in the same manner as mPdpn-Fc. 
Expression of recombinant murine VWF 
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The cDNA for murine VWF (mVWF), previously cloned into the mammalian expression 
vector pcDNA3.1, was transiently transfected into HEK293T cells using 10mM 
polyethylenimine as previously described [28]. Four days post transfection, cell media was 
harvested and centrifuged at 4000g for 15 min to remove dead cells. Recombinant mVWF 
was partially purified by passing over an ion-exchange column packed with Fractogel-EMD-
TMAE (Merck-Millipore) in 20mM Tris, 100mM NaCl, pH 7.8. Bound VWF was eluted with 
500mM NaCl and following extensive dialysis into 20mM Tris, pH 7.8 at 4°C, was 
concentrated using 100kDa cut-off spin filters (Amicon, Peterborough, UK). The final VWF 
concentration was determined by VWF ELISA. 
Blood isolation 
Blood was drawn from the inferior vena cava of anaesthetized and then CO2-asphyxiated 
mice into 5 U/mL heparin and 40 μM PPACK, and stained with 2 μM DiOC6.  Human blood 
was drawn into 4.5% sodium citrate (w/v).  No difference was observed using the alternative 
anticoagulant combination 5 U/mL heparin and 40 μM PPACK.   
Capillary flow assay 
Glass capillaries with internal dimensions of 1 x 0.1 mm were coated with 100 μg/ml fibrillar 
Horm collagen or 100 μg/ml mPdpn-Fc overnight at 4
o
C and then blocked with 5mg/ml heat 
denatured bovine serum albumin (BSA) in PBS. Whole blood was incubated with the 
fluorescent dye DiOC6 and inhibitors for 10 min at 37
o
C. Blood was perfused through a 
capillary at the desired shear rate for up to 4 min at 37
o
C as previously described [16]. 
Live imaging of platelet aggregate formation under flow was performed on an inverted 
stage microscope (DM IRB, Leica Microsystems Ltd, Milton Keynes UK) equipped with a 
digital camera (CoolSnap ES, Photometrics, Huntington Beach, CA) under fluorescent light 
for the duration of the experiment.  
Dot Blot assay 
A dot blot assay was used to test protein-ligand binding. The assay was carried out by 
dotting 0.1 µg of the target protein onto a nitrocellulose membrane (BioRad). After the dots 
were air dried, the membrane was blocked in 5% milk in PBS-Tween (0.5%: PBST) at room 
temperature for one hour. The membrane was incubated with ligand at 0.4 µg/ml in 2.5% 
milk in PBST overnight at 4
o
C. Next day, after washing, the membrane was incubated at 
room temperature with primary antibody of the ligand for 2 hours, followed by wash and 
then incubation with HRP conjugated secondary antibody for 1 hour. The membrane was 
visualized by ECL western blotting substrate (Thermo) on Li-COR Odyssey Fc system, with a 
developing time of 30 sec.  
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Surface plasmon resonance  
Surface plasmon resonance (SPR) binding studies were conducted using a Biacore T200 
machine (Biacore GE, Sweden) as described previously [3]. In brief, proteins were attached 
to the carboxymethylated dextran-coated surface of CM5 biosensor chips, using amine 
coupling chemistry. Experiments were performed in 10 mM HEPES pH 7.4, 150 mM NaCl, 3 
mM EDTA and 0.005% polysorbate 20 surfactant. Non-specific interactions were controlled 
for by subtraction of the signal from a reference blank flow cell. To avoid avidity effects with 
podoplanin which was expressed as a dimeric Fc-fusion protein, experiments were only 
performed with podoplanin immobilized on the chip surface. Raw data was analysed using 
Scrubber2 (BioLogic Software Pty Ltd, Australia), and KD values were obtained by nonlinear 
curve fitting using Graphpad Prism 5. 
Analysis  
Fluorescent images from the video capture of perfusion experiments were analysed using 
image J. Results from video capture are expressed as percentage area covered by platelets.   
Statistical analysis was performed using an unpaired Student’s t-test or one-way ANOVA 
followed by Dunnett’s post-test where appropriate, as indicated in the figure legends. 
Differences with p <0.05 were considered statistically significant. 
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Results  
Fc mPodoplanin (mPdpn-Fc) supports aggregation of mouse platelets at high shear 
To investigate a possible role of podoplanin in platelet adhesion in the vasculature, we 
investigated the ability of a dimerized form of mouse podoplanin to support platelet 
aggregation in conditions of flow using an in vitro blood flow system.  The high purity of the 
recombinant podoplanin (mPdpn-Fc), which is a recombinant Fc fusion of the mouse 
podoplanin extracellular domain, was investigated using SDS-PAGE under reducing and non-
reducing conditions (Supplemental Figure 1).   
Mouse blood was perfused over an immobilized monolayer of mPdpn-Fc using a range of 
venous and arterial shear rates (100 - 1000s
-1
) (Figure 1A). A control recombinant Fc protein 
did not support platelet adhesion at any of the shear rates (not shown).  Mouse platelets 
adhere and form small aggregates on a podoplanin-coated surface at 100s
-1
.  At the higher 
shear rate of 500s
-1
, platelets form fewer but larger, distinct aggregates. At an arterial shear 
rate of 1000s
-1
, podoplanin supported formation of large aggregates. There was no adhesion 
at 2000s
-1
 and above (not shown). Quantification of platelet coverage after 4 min of 
perfusion demonstrated a significant increase in percentage coverage at 1000s
-1 
compared 
with 100s
-1
 and 500s
-1
 (Figure 1B). 
Fc mPodoplanin induced platelet adhesion is dependent on CLEC-2  
To establish the role of CLEC-2 in adhesion and aggregation, blood from platelet-specific 
CLEC-2 deficient mice (PF4-Cre.CLEC-2
fl/fl
) was perfused over mPdpn-Fc coated capillaries. 
Deletion of CLEC-2 abolished platelet adhesion at 100s
-1
 and 1000s
-1
 compared with CLEC-
2
fl/fl
 littermates (Figure 2A and B).  In contrast, blood from PF4-Cre.CLEC-2
fl/fl 
mice 
aggregated normally on a collagen-coated capillary relative to littermate controls in 
agreement with previous results (Figure 2A) [16].  
Regulation of platelet aggregation on podoplanin  
Pharmacological inhibitors were used to investigate the role of platelet receptors and their 
signalling pathways in platelet adhesion to immobilized podoplanin. The Src family kinase 
inhibitor dasatinib abolished aggregation on podoplanin leaving only single platelets (Figure 
3A, B), consistent with a critical role for Src kinases in CLEC-2 signalling [26]. CLEC-2 
signalling is also dependent on the feedback agonists TxA2 and ADP [6,29]. In line with this, a 
combination of the cyclooxygenase inhibitor indomethacin and the P2Y12 receptor 
antagonist, Cangrelor, blocked aggregation on mouse podoplanin at 1000s
-1
 leaving only 
single platelets and small platelet clumps (Figure 3A, B).   
Aggregation of platelets is mediated by crosslinking of fibrinogen to integrin αIIbβ3  [30]. 
Inhibition of αIIbβ3 by the blocking peptide, epifibatide, markedly inhibited aggregation at 
1000s
-1 
(Figure 3A). Blocking the GPIbα-subunit of the VWF receptor GPIb-IX-V by the 
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monoclonal antibody p0p/B also markedly reduced platelet aggregation, leaving small 
platelet clumps (Figure 3A, B). These results indicate that platelet aggregation on 
podoplanin is driven by CLEC-2-dependent activation of Src kinases leading to release of the 
feedback agonists ADP and TxA2 and activation of integrin αIIbβ3.  The GPIb-IX-V receptor 
mediates tethering and capture of platelets in the growing thrombus through interaction 
with VWF.  The adhesion of single platelets in the presence of the GPIb blocking antibody 
indicates that this interaction is not required for initial platelet adhesion to podoplanin.  
Consistent with this, mouse VWF did not bind to mPdpn-Fc (Figure 3C).  Binding of mouse 
VWF to collagen and mPdpn-Fc with mCLEC-2-Fc served as positive controls (Figure 3C).  
Fc mPodoplanin (mPdpn-Fc) supports the aggregation of human platelets at venous rates 
of shear 
The above results demonstrate the unexpected observation that mouse podoplanin can 
support adhesion and aggregation of mouse platelets at both venous and arterial rates of 
flow.  The latter is in contrast to previous results for human podoplanin with human and 
mouse platelets [24,11].  To investigate whether mouse podoplanin is able to support 
adhesion and aggregation of human platelets, blood was perfused over a monolayer of 
mPdpn-Fc.  Human platelets form small aggregates on mPdpn-Fc coated surface at 100s
-1 
but not at a shear rate of 300s
-1
 and above (not shown).  Aggregation is reduced to single 
platelets in the presence of the Src kinase inhibitor, dasatinib (Figure 4A and B).  The αIIbβ3 
inhibitor, eptifibatide, blocked aggregation (Figure 4A and B).   
Mouse CLEC-2 and mouse podoplanin interact with high affinity 
We measured the binding affinity between mouse CLEC-2 and mouse podoplanin using SPR 
(Figure 5). In these studies we used dimeric mPdpn-Fc and monomeric podoplanin fused to 
a 6x Histidine tag (mPdpn-His). Both forms of mouse podoplanin showed a similar strong 
affinity to mCLEC-2-His of 15.3 ± 3.2 nM and 10.6 ± 1.3 nM respectively.  
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Discussion 
This study demonstrates for the first time the ability of immobilized dimeric mouse 
podoplanin to initiate mouse platelet activation and aggregation at venous and arterial rates 
of shear through the C-type lectin-like receptor, CLEC-2.  Aggregation on immobilized 
podoplanin is dependent on integrin αIIbβ3, the VWF receptor complex GPIb-IX-V, and the 
feedback mediators ADP and TxA2 indicating that it involves classical haemostasis. The Src 
kinase inhibitor, dasatinib, blocks aggregate formation consistent with aggregation being 
driven by activation of the C-type lectin-like receptor.  
Surface plasmon resonance demonstrates that mouse podoplanin binds to mouse CLEC-2 
with nanomolar affinity providing a molecular basis for platelet capture at arterial flow 
rates.  This contrasts with previous reports that human and mouse platelets are only able to 
form aggregates on human lymphatic endothelial cells, which express podoplanin, at venous 
rates of flow [11,24].   .  The difference in interspecies interactions supports the reduced 
interaction of human platel ts with recombinant mouse podoplanin observed in this study. 
Several studies have described glycosylation of conserved threonine residues in the 
podoplanin platelet activation (PLAG) domains as important for the podoplanin mediated 
activation of platelets [31,32].  These extracellular PLAG domains of podoplanin are highly 
conserved between mouse and human podoplanin (The alignment of human and mouse 
podoplanin can be found in Supplemental Figure 2).  Despite this conservation there are 
additional glycosylation sites throughout podoplanin which do not show conservation.   One 
of note is the presence of a predicted N-glycosylation site which, while found in mouse 
podoplanin, is absent in human podoplanin [31].   
It is recognized that the glycosylation of podoplanin is also dependent on the cell type in 
which is it expressed [33].  It is unclear to what extent differences in glycosylation impact on 
podoplanin function.  A previous report demonstrated no difference between recombinant 
human podoplanin expressed by a human cell line compared to human podoplanin 
expressed by Chinese Hamster Ovary (CHO) cells to induce the aggregation of human 
platelets [34].    
Classical haemostasis involves a number of stages. Platelets interact via GPIb with VWF 
immobilized to collagen and in turn collagen triggers platelet activation through the collagen 
receptor GPVI.  VWF is critical for capture of platelets in the high shear environment in 
arteries and arterioles [35-37]. GPVI activates Src and Syk tyrosine kinases [38,39] leading to 
secretion of the feedback agonists ADP and TxA2 [40,41]. A process of “inside out” signalling 
converts αIIbβ3 to an active confirmation and platelet-platelet interaction [42,43]. GPVI 
activates Src and Syk tyrosine kinases leading to activation of PLCγ2 and release of ADP and 
TxA2 [29]. 
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The present study provides evidence for a new pathway of haemostasis at high shear in 
which mouse podoplanin directly captures mouse platelets via CLEC-2.  This supports stable 
adhesion and aggregation through a pathway that is dependent on granule secretion and 
TxA2 formation. GPIb supports aggregation through tethering of platelets into the 
aggregate.  We have previously demonstrated the importance of Src family kinases in CLEC-
2 signalling, including in the adhesion of platelets to podoplanin through regulation of 
clustering of CLEC-2 and podoplanin [26]. 
Podoplanin is expressed on the neuroepithelium lining the cerebrovasculature in mice in 
mid-gestation [10] where it makes contact with platelets [22,23]. Loss of podoplanin 
expression on neuroepithelial cells phenocopies the haemorrhaging that seen in mice 
deficient in podoplanin or CLEC-2 [10]. Mice lacking the αIIb-subunit of the integrin αIIbβ3 
also exhibit haemorrhaging in the cerebrovasculature although this is less severe than that 
that seen in mice deficient in CLEC-2 or podoplanin.  This suggests a haemostatic and non-
haemostatic role for the podoplanin-CLEC-2 axis in development of the cerebral vasculature. 
Human platelets interact with podoplanin-expressing human lymphatic endothelial cells and 
with recombinant human podoplanin at low but not intermediate or high shear rates [24]. 
This is in line with the reported affinity between human podoplanin and human CLEC-2 of 24 
µM [25], which is three orders of magnitude lower than that for mouse podoplanin and 
mouse CLEC-2. The difference in affinity leads to uncertainty as to whether the present 
findings can be extrapolated to the cerebrovasculature in human brain [44]. IVH is a 
common pathology in preterm neonatal babies who often exhibit low platelet counts [19-
21]. The role of CLEC-2 in this process remains to be determined.  
In conclusion, our study demonstrates the novel finding that mouse podoplanin initiates 
formation of stable platelet aggregates at high shear. We speculate that this is important 
during development of the mouse cerebrovasculature triggered by podoplanin on 
neuroepithelial cells and represents a specialised form of haemostasis. 
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Figures 
Figure 1: Fc mPodoplanin (mPdpn-Fc) supports the aggregation of mouse platelets at high 
shear 
A. Anticoagulated blood from wild-type mice was perfused through mPdpn-Fc-coated 
capillary tubes at the indicated shear rates. Platelets were fluorescently labelled with DiOC6 
before being perfused. Representative images were taken in real time by fluorescence 
microscopy.  Arrow indicates the direction of flow.  Scale bar 20 μm. Images are 
representative of 4 independent experiments. B. (i) Quantitation of mouse platelet area 
coverage following blood perfusion.   Statistical analysis preformed using a one way ANOVA 
followed by a Dunnett's multiple comparisons test (*=p<0.05, **=p<0.01). The threshold 
image at 4 minutes is presented in the right hand panel.  Error bars represent standard 
deviation. 
Figure 2:  Fc mpodoplanin (mPdpn-Fc) mediated platelet aggregation is dependent on the 
platelet receptor CLEC-2 
A. Anticoagulated blood from PF4-Cre.CLEC-2
fl/fl 
mice and CLEC-2
fl/fl 
littermates was perfused 
through mPdpn-Fc and collagen-coated capillary tubes at the indicated shear rates. Platelets 
were fluorescently labelled with DiOC6 before being perfused. Representative images were 
taken in real time by fluorescence microscopy.  Arrow indicates the direction of flow.  Scale 
bar 20 μm. Images are representative of 3 independent experiments. B. Quantitation of 
platelet coverage following blood perfusion. Statistical analysis was performed using an 
unpaired one tailed t test (*** = p<0.001). Error bars represent the standard deviation. 
Figure 3: Effect of inhibitors on platelet aggregation on podoplanin under shear 
A. Anticoagulated wild type (WT) mouse blood was perfused through mPdpn-Fc -coated 
capillary tubes at 1000s
-1
. Platelets were fluorescently labelled with DiOC6 before being 
perfused and ten images taken post perfusion, with representative images shown: vehicle 
control image (Veh: DMSO), Dasatinib (Das: 10 µM), eptifibatide (Eptifib: 9 µM), 
Indomethacin (Indo: 10 µM) and Cangrelor (Cang: 1 µM), p0p/B antibody (50 µg/ml). Arrow 
indicates the direction of flow. Scale bar 20 µm. Images are representative of 4 independent 
experiments. B. Quantitation of platelet coverage following blood perfusion.  Statistical 
analysis was performed using a one way ANOVA followed by a Dunnett's multiple 
comparisons test to the vehicle control, error bars represent standard deviation. * = p<0.05, 
** = p<0.01, *** = p<0.001. C. Dot blot assay to determine ligand binding. 0.1 µg of protein 
(collagen, mPdpn-Fc and mCLEC-2-Fc) was air dried to nitrocellulose membrane.  Following 
incubation with ligand (VWF, mCLEC-2-Fc and mPdpn-Fc) bound ligand was determined 
using the indicated antibodies.   
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Figure 4: Fc mPodoplanin supports aggregation of human platelets at low shear 
A. Anticoagulated blood from human was perfused through Fc mpodoplanin (mPdpn-Fc)-
coated capillary tubes at the indicated shear rates. Platelets were fluorescently labelled with 
DiOC6 before being perfused. Representative images were taken in real time by 
fluorescence microscopy at 100s
-1
: vehicle control (Veh: DMSO), dasatinib (Das: 10 µM), 
eptifibatide (Eptifib: 9 µM). Arrow indicates the direction of flow.  Scale bar 20 μm. Error 
bars represent standard deviation. Images are representative of 3 independent 
experiments.  B. Quantitation of human platelet coverage following blood perfusion.  
Statistical analysis was performed using a one way ANOVA followed by a Dunnett's multiple 
comparisons test (* = p<0.05, ** = p<0.01). Error bars represent standard deviation. 
Figure 5: Mouse CLEC-2 and mouse podoplanin interact directly with high affinity 
A. Sensorgram from equilibrium–based binding experiment after subtraction of the signal 
from a control flow cell surface. Different concentrations of CLEC-2 were injected over 
surfaces coupled with Fc mouse podoplanin (mPdpn-Fc) and His tagged mouse podoplanin 
(mPdpn-His).  The dissociation phase of the sensorgrams is observed following a 10 minute 
injection period, indicated by the closed arrow heads.  Start of the flow cell surface 
regeneration is indicated on the sensograms by the open arrow heads.  B. Plot of the 
equilibrium binding response from the sensorgram of mPdpn-Fc and mPdpn-His as a 
function of CLEC-2 concentration. The curve is the best fit to the experimental data as 
calculated by GraphPad Prism 5.  The affinity between mouse CLEC-2 and mouse podoplanin 
was calculated to be 15.3 ± 3.2 nM when using mPdpn-Fc and 10.6 ± 1.3 nM when using 
mPdpn-His. C. Equilibrium binding response of mPdpn-Fc and mPdpn-His as a function of 
CLEC-2 concentration presented as a log-scale.  
 
Page 17 of 25
URL: http://mc.manuscriptcentral.com/cpla E-mail: P.Harrison.1@bham.ac.uk
Platelets
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
  
 
 
Figure 1: Fc mPodoplanin (mPdpn-Fc) supports the aggregation of mouse platelets at high shear  
A. Anticoagulated blood from wild-type mice was perfused through mPdpn-Fc-coated capillary tubes at the 
indicated shear rates. Platelets were fluorescently labelled with DiOC6 before being perfused. Representative 
images were taken in real time by fluorescence microscopy.  Arrow indicates the direction of flow.  Scale bar 
20 µm. Images are representative of 4 independent experiments. B. (i) Quantitation of mouse platelet area 
coverage following blood perfusion.   Statistical analysis preformed using a one way ANOVA followed by a 
Dunnett's multiple comparisons test (*=p<0.05, **=p<0.01). The threshold image at 4 minutes is 
presented in the right hand panel.  Error bars represent standard deviation.  
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Figure 2:  Fc mpodoplanin (mPdpn-Fc) mediated platelet aggregation is dependent on the platelet receptor 
CLEC-2  
A. Anticoagulated blood from PF4-Cre.CLEC-2fl/fl mice and CLEC-2fl/fl littermates was perfused through 
mPdpn-Fc and collagen-coated capillary tubes at the indicated shear rates. Platelets were fluorescently 
labelled with DiOC6 before being perfused. Representative images were taken in real time by fluorescence 
microscopy.  Arrow indicates the direction of flow.  Scale bar 20 µm. Images are representative of 3 
independent experiments. B. Quantitation of platelet coverage following blood perfusion. Statistical analysis 
was performed using an unpaired one tailed t test (*** = p<0.001). Error bars represent the standard 
deviation.  
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Figure 3: Effect of inhibitors on platelet aggregation on podoplanin under shear  
A. Anticoagulated wild type (WT) mouse blood was perfused through mPdpn-Fc -coated capillary tubes at 
1000s-1. Platelets were fluorescently labelled with DiOC6 before being perfused and ten images taken post 
perfusion, with representative images shown: vehicle control image (Veh: DMSO), Dasatinib (Das: 10 µM), 
eptifibatide (Eptifib: 9 µM), Indomethacin (Indo: 10 µM) and Cangrelor (Cang: 1 µM), p0p/B antibody (50 
µg/ml). Arrow indicates the direction of flow. Scale bar 20 µm. Images are representative of 4 independent 
experiments. B. Quantitation of platelet coverage following blood perfusion.  Statistical analysis was 
performed using a one way ANOVA followed by a Dunnett's multiple comparisons test to the vehicle control, 
error bars represent standard deviation. * = p<0.05, ** = p<0.01, *** = p<0.001. C. Dot blot assay to 
determine ligand binding. 0.1 µg of protein (collagen, mPdpn-Fc and mCLEC-2-Fc) was air dried to 
nitrocellulose membrane.  Following incubation with ligand (VWF, mCLEC-2-Fc and mPdpn-Fc) bound ligand 
was determined using the indicated antibodies.  
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Figure 4: Fc mPodoplanin supports aggregation of human platelets at low shear  
A. Anticoagulated blood from human was perfused through Fc mpodoplanin (mPdpn-Fc)-coated capillary 
tubes at the indicated shear rates. Platelets were fluorescently labelled with DiOC6 before being perfused. 
Representative images were taken in real time by fluorescence microscopy at 100s-1: vehicle control (Veh: 
DMSO), dasatinib (Das: 10 µM), eptifibatide (Eptifib: 9 µM). Arrow indicates the direction of flow.  Scale bar 
20 µm. Error bars represent standard deviation. Images are representative of 3 independent 
experiments.  B. Quantitation of human platelet coverage following blood perfusion.  Statistical analysis was 
performed using a one way ANOVA followed by a Dunnett's multiple comparisons test (* = p<0.05, ** = 
p<0.01). Error bars represent standard deviation.  
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Figure 5: Mouse CLEC-2 and mouse podoplanin interact directly with high affinity  
A. Sensorgram from equilibrium–based binding experiment after subtraction of the signal from a control flow 
cell surface. Different concentrations of CLEC-2 were injected over surfaces coupled with Fc mouse 
podoplanin (mPdpn-Fc) and His tagged mouse podoplanin (mPdpn-His).  The dissociation phase of the 
sensorgrams is observed following a 10 minute injection period, indicated by the closed arrow heads.  Start 
of the flow cell surface regeneration is indicated on the sensograms by the open arrow heads.  B. Plot of the 
equilibrium binding response from the sensorgram of mPdpn-Fc and mPdpn-His as a function of CLEC-2 
concentration. The curve is the best fit to the experimental data as calculated by GraphPad Prism 5.  The 
affinity between mouse CLEC-2 and mouse podoplanin was calculated to be 15.3 ± 3.2 nM when using 
mPdpn-Fc and 10.6 ± 1.3 nM when using mPdpn-His. C. Equilibrium binding response of mPdpn-Fc and 
mPdpn-His as a function of CLEC-2 concentration presented as a log-scale.  
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Supplemental Figure 1: Elution fractions of recombinant FcmPdpn.  
The purity of the recombinant mouse podoplanin extracellular domain expressed as an Fc 
fusion was determined under reducing and non-reducing SDS-PAGE followed by Coomassie 
protein staining.  Under non-reducing condition the Fc fusion migrates at a high molecular 
weight dimer.  Under reducing conditions reduction of the Fc intra-chain disulphide bonds in 
the recombinant protein occurs leading to a lower molecular weight monomer.  
Supplemental Figure 2: Protein alignment of mouse and human podoplanin. 
Podoplanin sequences from human and mouse were aligned using TCoffee web-based 
software [1] and presented using ESPript3 [2]. The extracellular domain contains conserved 
threonine residues within the platelet activating (PLAG) domains 1 and 3, indicated by a *.  
The predicted N-glycosylation site in mouse podoplanin is indicated by a box.  The signal 
peptide and transmembrane domain are indicated. 
Supplementary references 
[1] Di Tommaso P, Moretti S, Xenarios I, Orobitg M, Montanyola A, Chang JM, Taly JF, Notredame C 
T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using 
structural information and homology extension. Nucleic acids research 2011;39:W13-17. 
[2] Robert X, Gouet P Deciphering key features in protein structures with the new ENDscript server. 
Nucleic acids research 2014;42:W320-324. 
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  Figure S1 
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Figure S2 
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